Photo Cred: Jakayla Toney/Unsplash By Katherine Shagoury A novel coronavirus (COVID-19) infection may prompt Guillain-Barré syndrome, according to new research published in the journal Brain. Guillain-Barré syndrome is an autoimmune...
Read MorePhoto Cred: Christian Bowen/Unsplash By Katherine Shagoury Women who receive the mRNA novel coronavirus (COVID-19) vaccine during pregnancy pass high levels of antibodies to their babies, according to a new...
Read MorePhoto Cred: Testalize/Unsplash By Katherine Shagoury Infection with SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), leads to a unique response from the human immune system, with a distinct...
Read MorePhoto Cred: Mat Napo/Unsplash By Katherine Shagoury An expert review by an international group of scientists concluded that, even for the delta variant, vaccine efficacy against severe novel coronavirus (COVID-19)...
Read MorePhoto Cred: SJ Objio/Unsplash By Katherine Shagoury After years of steady reductions in healthcare-associated infections, significantly higher rates of four out of six routinely tracked infections were observed in hospitals...
Read MorePhoto Cred: Andrea Piacquadio/Pexels By Katherine Shagoury Children who develop symptoms of the novel coronavirus (COVID-19) typically get better after six days, and the number who experience symptoms beyond four...
Read MorePhoto Cred: ThisisEngineering RAEng/Unsplash By Katherine Shagoury Researchers from Yale University have discovered the underlying genetic cause of a rare childhood disorder that mimics inflammatory bowel disease, a finding that...
Read MorePhoto Cred: Unsplash By Katherine Shagoury A systematic evaluation of research on the risk and outcomes of the novel coronavirus (COVID-19) in patients with psoriasis and psoriatic arthritis treated with...
Read More